Novo Nordisk’s Wegovy and copyright, both equally run by semaglutide, have revolutionized obesity procedure through unprecedented weight loss benefits.Issues with diabetic retinopathy: Diabetic retinopathy is a watch situation causing damage to the blood vessels in the eye that could manifest in those with diabetes.By 2022 the popularity of Novo'